Chikungunya infected children are being reported these days, said Dr. Deepal Perera, a specialist at the Lady Ridgeway ...

Cases of Chikungunya among children are being reported in recent days, Lady Ridgeway Hospital’s Consultant Paediatrician Dr. Deepal Perera said. Dr.

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Valneva has announced positive outcomes from its Phase III trial of the single-shot IXCHIQ chikungunya virus vaccine in ...

BENGALURU: Vaccines and antiviral, although not very effective are there for flu virus, however there are none which are clinically approved for mosquito borne ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...

Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to ...

Chikungunya virus (CHIKV) is a mosquito-borne virus that has gained significant attention due to its widespread outbreaks and the severe health impacts it can cause. The disease, known as ...

Valneva (VALN) stock rose after the company posted new Phase 3 trial data for its chikungunya vaccine, Ixchiq, in adolescents aged 12-17. Read more here.

the company and Pfizer reported positive data from the Phase II trial of a second booster dose of their Lyme disease vaccine candidate. "Valneva announces positive outcomes from chikungunya ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Chikungunya virus (CHIKV) causes an acute febrile disease characterized by severe arthralgia in the small joints. This arthralgia is highly debilitating and can be chronic. CHIKV circulates ...